SN-4

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameSN-4
Drug Alias NameSN-4
ClassificationOther
Mechanisms of ActionDisintegrin and metalloproteinase domain-containing protein 17 inhibitors
TargetsDisintegrin and metalloproteinase domain-containing protein 17
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKumamoto University
China Registration ClassN/A

Develop Information

Active CompaniesKumamoto University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A